openPR Logo
Press release

Asthma and COPD Drugs Market Trends, Size, Forecast - 2019-2025

05-26-2020 10:24 AM CET | Health & Medicine

Press release from: Orion Market Research

Asthma and COPD Drugs Market

Asthma and COPD Drugs Market

Increasing prevalence of respiratory diseases such as asthma and COPD across the globe further prples the demand of asthma and COPD drugs. As per Centre for Diseases Control and Prevention, about 1 in 13 people in the US have asthma in the US, equal to 25 million people. About 7.5% of adults and 8.5% of children are affected by it in the country. As per Asthma UK, about 5.4 million people are suffering are suffering from asthma in the UK in 2016. Out of 5.4 million people, asthma is prevalent in 4.3 million adults and 1.1 million in children. National Healthcare Service of the UK is spending about $1 billion each year to treat and caring of people with asthma. As per WHO, India is estimated to have about 15-20 million asthma patients in 2017. It is also on high rise in China, as per Asia Asthma Development Board, there were about 36.7 patients of asthma per 100,000 people. There are more than 30 million people living with Asthma in the China. In Australia, there are about 2.5 million people living with asthma. Therefore the increasing prevalence further provide demand of drugs that further propels the market growth.

Increasing R&D further boost the Asthma and COPD drugs Market
Researchers are continuously looking for new ways to treat Asthma and COPD and research in various areas such as early detection, new drug therapies and new surgical techniques. Various studies and trails have the method of lung accumulating the damage and way to treat the damage before it respiratory diseases become COPD. Companies such as Vertex Pharmaceuticals, Merck, GlaxoSmithKline, Novartis, AstraZeneca are continuously working toward the research and development. In period of 2015-18, various drugs of these companies have been cleared by FDA for treating respiratory diseases. For instance in April, 2016 AstraZeneca got an FDA approval for Bevespi Aerosphere which have application in treatment of COPD. Before this, Teva Pharmaceuticals got an FDA approval for Cinqair (reslizumab) in March, 2016 which can be used to treat severe asthma.

Request a free sample of our report on Asthma and COPD Drugs Market: https://www.omrglobal.com/request-sample/asthma-and-copd-drugs-market

Substantial opportunities in emerging markets

A significant growth in the healthcare facilities related to respiratory diseases has been observed in the emerging economies such as China, India and Brazil. Various factors such as increasing air pollution, increasing disposable income & expenditure on healthcare are attracting market players to serve their healthcare organizations. Specifically, Asia-Pacific region is considered to be the most emerging market due to significant growth of healthcare system in Asia-Pacific countries such as India, China, and South Korea. Asia pacific region is forecast to witness immense growth and development in healthcare sector due to significant investment by government and major market players, favourable government policies, high patient base. Asia-Pacific region covers more than 60% of global population, have high prevalence of respiratory diseases such as asthma and COPD therefore provide significant opportunity to the market growth.

A full report of Asthma and COPD Drugs Market is available at: https://www.omrglobal.com/industry-reports/asthma-and-copd-drugs-market

Global Asthma and COPD Drugs Market Segmentation

By Disease Type
o Asthma
o COPD

By Drug class
o Anti-inflammatory Drugs
o Combination Drugs
o Monoclonal Antibodies
o Bronchodilators

By Region

North America
o US
o Canada

Europe
o Germany
o UK
o France
o Spain
o Italy
o Rest of Europe

Asia-Pacific
o China
o Japan
o India
o Rest of Asia-Pacific

Rest of the World
o Latin America
o The Middle East and Africa

Company Profiles
o Amgen Inc.
o AptarGroup, Inc.
o AstraZeneca PLC
o Boehringer Ingelheim International GmbH
o Cipla Ltd.
o F. Hoffmann-La Roche Ltd.
o GlaxoSmithKline PLC
o Grifols, S.A.
o Glenmark Pharmaceuticals
o Merck & Co., Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/asthma-and-copd-drugs-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asthma and COPD Drugs Market Trends, Size, Forecast - 2019-2025 here

News-ID: 2057649 • Views:

More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sustainability Preferences
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become
Railway Management System Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033. Railway Management System Market Overview The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033. Monocalcium Phosphate Market Overview Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033. Automotive Lubricants Market Overview The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by

All 5 Releases


More Releases for COPD

Copd Drugs Market Size Analysis by Application, Type, and Region: Forecast to Co …
USA, New Jersey- According to Market Research Intellect, the global Copd Drugs market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. Because respiratory problems are becoming more common worldwide, especially among smokers and older populations, the market for COPD medications is expanding steadily. The need
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market 2024-2030 Growth: …
Growth: Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Insights : For stakeholders, an optimistic view is shown by the thorough study of the worldwide "Chronic Obstructive Pulmonary Disease (COPD) Treatment market". The research provides specifics on the market's historical and present conditions as well as projected trends and size. Decision-makers may navigate the competitive environment and investment possibilities in the Chronic Obstructive Pulmonary Disease (COPD) Treatment market with the use of
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market - Breathing Sol …
Newark, New Castle, USA - new report, titled Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Obstructive Pulmonary Disease (COPD) Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Obstructive Pulmonary Disease
Asthma & COPD Drugs Market - Breathe Freely, Live Fully: Empowering Respiratory …
Newark, New Castle, USA - new report, titled Asthma & COPD Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Asthma & COPD Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Asthma & COPD Drugs market. The report offers
Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's. It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be